Kaylin Bechard, Anita Truong, Samuel A J Lowe, Pamela Mathura, Reidar Hagtvedt, Marlene T Dytoc
{"title":"评估外阴生活质量指数对新患者皮肤病学评估的影响。","authors":"Kaylin Bechard, Anita Truong, Samuel A J Lowe, Pamela Mathura, Reidar Hagtvedt, Marlene T Dytoc","doi":"10.1177/12034754251347552","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prevalence of vulvar diseases has a significant impact on quality of life (QoL). Measurement may not be consistently collected during assessments. Incorporating a QoL measurement tool may help optimize patient-centred care.</p><p><strong>Objective: </strong>To determine the impact of the validated Vulvar Quality of Life Index (VQLI) questionnaire during consultation assessments.</p><p><strong>Methods: </strong>A randomized controlled trial from a single dermatology centre was completed over 10 months. The intervention group completed the VQLI at the baseline/initial appointment, and both the intervention and control groups completed the questionnaire at follow-up, with these scores compared. Secondary outcomes compared scores within the intervention group; analyzed treatment adherence; and surveyed self-reported symptom improvement, whether patient health-related concerns were addressed, and well-being. Data were analyzed descriptively, with significance between means and proportions assessed using <i>t</i>-tests and Fisher's exact tests, respectively.</p><p><strong>Results: </strong>Forty-two patients participated. Scores within the intervention group, baseline (18) versus follow-up (8.3), were statistically significant. Follow-up VQLI scores in the intervention group (n = 23), 8.3, trended lower than the control (n = 19), 12.8, but were not statistically significant (<i>P</i> = .1529). Although treatment adherence (<i>P</i> = .428), symptom improvement (<i>P</i> = .684), and feeling of whether health-related concerns were addressed (<i>P</i> = .391) were similar, improvement in well-being (<i>P</i> = .017) in the intervention group was statistically significant.</p><p><strong>Conclusions: </strong>In addition to the use of VQLI in vulvar dermatology assessments as an aid in identifying the impact of vulvar conditions on QoL, we recommend its use to improve the patients' sense of well-being.</p>","PeriodicalId":15403,"journal":{"name":"Journal of Cutaneous Medicine and Surgery","volume":" ","pages":"12034754251347552"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluating the Impact of the Vulvar Quality of Life Index for New Patient Dermatology Assessments.\",\"authors\":\"Kaylin Bechard, Anita Truong, Samuel A J Lowe, Pamela Mathura, Reidar Hagtvedt, Marlene T Dytoc\",\"doi\":\"10.1177/12034754251347552\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The prevalence of vulvar diseases has a significant impact on quality of life (QoL). Measurement may not be consistently collected during assessments. Incorporating a QoL measurement tool may help optimize patient-centred care.</p><p><strong>Objective: </strong>To determine the impact of the validated Vulvar Quality of Life Index (VQLI) questionnaire during consultation assessments.</p><p><strong>Methods: </strong>A randomized controlled trial from a single dermatology centre was completed over 10 months. The intervention group completed the VQLI at the baseline/initial appointment, and both the intervention and control groups completed the questionnaire at follow-up, with these scores compared. Secondary outcomes compared scores within the intervention group; analyzed treatment adherence; and surveyed self-reported symptom improvement, whether patient health-related concerns were addressed, and well-being. Data were analyzed descriptively, with significance between means and proportions assessed using <i>t</i>-tests and Fisher's exact tests, respectively.</p><p><strong>Results: </strong>Forty-two patients participated. Scores within the intervention group, baseline (18) versus follow-up (8.3), were statistically significant. Follow-up VQLI scores in the intervention group (n = 23), 8.3, trended lower than the control (n = 19), 12.8, but were not statistically significant (<i>P</i> = .1529). Although treatment adherence (<i>P</i> = .428), symptom improvement (<i>P</i> = .684), and feeling of whether health-related concerns were addressed (<i>P</i> = .391) were similar, improvement in well-being (<i>P</i> = .017) in the intervention group was statistically significant.</p><p><strong>Conclusions: </strong>In addition to the use of VQLI in vulvar dermatology assessments as an aid in identifying the impact of vulvar conditions on QoL, we recommend its use to improve the patients' sense of well-being.</p>\",\"PeriodicalId\":15403,\"journal\":{\"name\":\"Journal of Cutaneous Medicine and Surgery\",\"volume\":\" \",\"pages\":\"12034754251347552\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cutaneous Medicine and Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/12034754251347552\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cutaneous Medicine and Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/12034754251347552","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Evaluating the Impact of the Vulvar Quality of Life Index for New Patient Dermatology Assessments.
Background: The prevalence of vulvar diseases has a significant impact on quality of life (QoL). Measurement may not be consistently collected during assessments. Incorporating a QoL measurement tool may help optimize patient-centred care.
Objective: To determine the impact of the validated Vulvar Quality of Life Index (VQLI) questionnaire during consultation assessments.
Methods: A randomized controlled trial from a single dermatology centre was completed over 10 months. The intervention group completed the VQLI at the baseline/initial appointment, and both the intervention and control groups completed the questionnaire at follow-up, with these scores compared. Secondary outcomes compared scores within the intervention group; analyzed treatment adherence; and surveyed self-reported symptom improvement, whether patient health-related concerns were addressed, and well-being. Data were analyzed descriptively, with significance between means and proportions assessed using t-tests and Fisher's exact tests, respectively.
Results: Forty-two patients participated. Scores within the intervention group, baseline (18) versus follow-up (8.3), were statistically significant. Follow-up VQLI scores in the intervention group (n = 23), 8.3, trended lower than the control (n = 19), 12.8, but were not statistically significant (P = .1529). Although treatment adherence (P = .428), symptom improvement (P = .684), and feeling of whether health-related concerns were addressed (P = .391) were similar, improvement in well-being (P = .017) in the intervention group was statistically significant.
Conclusions: In addition to the use of VQLI in vulvar dermatology assessments as an aid in identifying the impact of vulvar conditions on QoL, we recommend its use to improve the patients' sense of well-being.
期刊介绍：
Journal of Cutaneous Medicine and Surgery (JCMS) aims to reflect the state of the art in cutaneous biology and dermatology by providing original scientific writings, as well as a complete critical review of the dermatology literature for clinicians, trainees, and academicians. JCMS endeavours to bring readers cutting edge dermatologic information in two distinct formats. Part of each issue features scholarly research and articles on issues of basic and applied science, insightful case reports, comprehensive continuing medical education, and in depth reviews, all of which provide theoretical framework for practitioners to make sound practical decisions. The evolving field of dermatology is highlighted through these articles. In addition, part of each issue is dedicated to making the most important developments in dermatology easily accessible to the clinician by presenting well-chosen, well-written, and highly organized information in a format that is interesting, clearly presented, and useful to patient care.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
